PPAR-γ Ligand Inhibits Nasopharyngeal Carcinoma Cell Proliferation and Metastasis by Regulating E2F2

Figure 4

E2F2 and PPAR-γ expression in CNE1 and CNE2 nasopharyngeal carcinoma cells after treatment with PPAR-γ ligand. (a, b) Western blotting was performed to detect the expression of E2F2, PPAR-γ, and GAPDH in CNE1 and CNE2 cells after treatment with dose-dependent PPAR-γ agonist Rog. (c, d) Western blotting was performed to detect the expression of E2F2, PPAR-γ, and GAPDH in CNE1 and CNE2 cells after treatment with PPAR-γ agonist (rosiglitazone, Rog) and PPAR-γ antagonist (GW9662).

(a)

(b)

(c)

(d)